Skip to content
INJECTABLE
MUCOMIX INJ
MUCOMIX INJ
By SAMARTH
Best deal on the Internet
Prescription Required
Couldn't load pickup availability
Check Availability
Rapid 3-4 Day Delivery,Tiny Extra Fee!
-
Pet Safe
-
Best Quality
-
Fast Delivery
-
Secure Payment
Collapsible content
About Product
Mucomix Injection by Samarth Life Sciences is a prescription-only, clinically critical injectable formulation of N-Acetylcysteine (NAC), designed to address two of the most urgent medical emergencies encountered in both human and veterinary clinical settings paracetamol (acetaminophen) toxicity and the management of thick, obstructive mucus secretions in respiratory tract diseases. Paracetamol overdose is one of the leading causes of acute liver failure, and the therapeutic window for effective intervention is dangerously narrow making the rapid, accurate administration of this antidote a life-or-death decision. Simultaneously, in conditions such as bronchitis, emphysema, bronchiectasis, and cystic fibrosis, excessive and viscous mucus can severely compromise airway patency and respiratory function. Mucomix Injection targets both these pathologies through a single, well-established active molecule with decades of clinical validation. Animeal is proud to offer Mucomix Injection as part of our curated selection of critical care pharmaceutical solutions for veterinary use, available for prescription-guided purchase through our platform.
Ingredients:
N-Acetylcysteine (NAC) 400 mg per 2 ml ampoule: (N-acetyl-L-cysteine; CAS No. 616-91-1) N-Acetylcysteine is a synthetic derivative of the naturally occurring amino acid L-cysteine, and its therapeutic action operates across two distinct but interconnected physiological pathways.
As a Mucolytic Agent: NAC directly targets the disulfide bonds within the glycoprotein matrix of mucus. At the biochemical level, its free thiol (-SH) group cleaves the disulfide bridges that maintain the structural rigidity and high viscosity of mucus polymers. This depolymerisation of mucus macromolecules reduces mucosal viscosity and elasticity, facilitating mucociliary clearance and making expectoration significantly easier. This action alleviates airway obstruction and improves respiratory function in conditions characterised by mucus hypersecretion.
As a Hepatoprotective Antidote: In the context of paracetamol toxicity, NAC functions as both a direct precursor to glutathione (GSH) and as a direct antioxidant. When paracetamol is metabolised in excess, the cytochrome P450 enzyme system generates a highly reactive hepatotoxic metabolite, N-acetyl-p-benzoquinone imine (NAPQI). Under normal conditions, NAPQI is rapidly conjugated and neutralised by hepatic glutathione. In overdose scenarios, glutathione stores become rapidly depleted, allowing NAPQI to accumulate and covalently bind to hepatocellular proteins, triggering oxidative stress, mitochondrial dysfunction, and ultimately necrotic cell death. NAC replenishes intracellular cysteine stores the rate-limiting substrate for glutathione biosynthesis thereby restoring GSH levels, neutralising NAPQI, and protecting hepatocytes from irreversible damage. Additionally, NAC exerts direct antioxidant activity, scavenging reactive oxygen species (ROS) independently of the GSH pathway, and improves microcirculatory blood flow in the liver, further reinforcing hepatic recovery.
Features and Benefits
Critical-Window Liver Protection in Toxicity Em...
Critical-Window Liver Protection in Toxicity Emergencies:
Mucomix Injection delivers N-Acetylcysteine intravenously, restoring hepatic glutathione reserves within the critical 8-hour post-overdose window during which liver damage is most reversible. For cases presenting beyond this window, the formulation continues to provide meaningful hepatoprotection up to 24 hours post-ingestion, making it the preferred choice of emergency and veterinary clinicians managing acute paracetamol toxicity in companion animals and human patients alike.
Cutting-Edge Mucolytic Action for Respiratory Clearance:
By directly cleaving the molecular bonds that give pathological mucus its gel-like consistency, Mucomix Injection restores natural mucociliary clearance and alleviates the airway obstruction that defines chronic bronchopulmonary conditions. In pets suffering from upper respiratory infections or structural lung diseases, this mucus-thinning action can be the difference between distressed, laboured breathing and restored respiratory comfort.
Dual-Pathway Antioxidant Defence:
Beyond its role as a glutathione precursor, NAC directly scavenges free radicals and reactive oxygen species at the cellular level, providing a second independent layer of antioxidant protection. This dual mechanism makes Mucomix Injection particularly valuable in clinical scenarios where oxidative stress from toxin exposure or chronic pulmonary inflammation is driving progressive organ or tissue damage.
Rapid Intravenous Bioavailability:
As an injectable formulation administered intravenously, Mucomix bypasses the limitations of oral bioavailability entirely, delivering therapeutic concentrations of N-Acetylcysteine directly into systemic circulation with immediate onset. This pharmacokinetic advantage is decisive in time-critical emergencies, where every hour without adequate antidotal intervention increases the risk of irreversible liver damage.
Clinically Validated Safety Profile:
N-Acetylcysteine has an extensive, well-characterised safety record across decades of clinical use in both human and veterinary medicine. Its side effect profile is well understood and manageable by qualified clinicians, and its mechanism of action is non-toxic to healthy hepatocytes, making it a reliable tool in the hands of experienced veterinary and medical professionals.
Usage and Applications
How to Use:Mucomix Injection must be administer...
How to Use:
Mucomix Injection must be administered exclusively by a qualified veterinarian or licensed medical professional in a clinical or hospital setting. It is not suitable for self-administration under any circumstances. The injection is delivered as an intravenous infusion (IV drip) and must be appropriately diluted in a compatible IV solution as directed by the attending clinician. The dose, infusion rate, and duration of treatment are determined by the veterinarian or physician based on the species, body weight, the nature and severity of the presenting condition, and the time elapsed since toxic exposure. In the context of paracetamol overdose, initiation of treatment should not be delayed pending the development of clinical symptoms intervention must begin as soon as a toxic ingestion is suspected. For mucolytic indications, the number of doses and treatment duration will be guided by the clinician's assessment of the patient's respiratory response. Do not mix Mucomix Injection with antibiotics in the same infusion unless directed by the prescribing professional, as interactions may reduce the efficacy of both agents.
Storage Advice:
Store unopened Mucomix Injection ampoules in a cool, dry place below 25°C, away from direct sunlight and sources of heat. Do not freeze. Once the ampoule has been opened, the contents must be used immediately and any unused solution must be discarded do not retain opened ampoules for later use. Handle with standard pharmaceutical care; the solution should be visually inspected for particulates or discolouration prior to administration, and any ampoule showing signs of damage or compromise should not be used. Store in compliance with local controlled medicine handling protocols where applicable. Do not use after the best-before date printed on the ampoule or outer packaging.
About the Brand:
Samarth Life Sciences Pvt. Ltd. traces its origins to 1963, founded by Mr. Gunwantlal Shah in Mumbai, Maharashtra, with a mission to bring life-saving critical care molecules to the Indian medical fraternity and global markets. Operating under stringent WHO-GMP compliant manufacturing standards, with facilities in Baddi (Himachal Pradesh) and Tumkur (Karnataka) approved by major international regulatory bodies, Samarth has built a reputation for pharmaceutical integrity and clinical relevance across decades of operation. The company's R&D philosophy is firmly anchored in addressing unmet medical needs through innovative, proprietary formulations particularly in the domains of critical care, hepatology, pulmonology, and emergency medicine. Samarth's products, including Mucomix, are exported to South America, the United Kingdom, South East Asia, and multiple African markets, reflecting a global trust in their manufacturing quality and therapeutic efficacy. This unwavering commitment to rigorous standards and life-saving innovation aligns with Animeal's commitment to providing only the most credible, clinically grounded pharmaceutical solutions for your pet's care. Discover Samarth Life Sciences today.
Disclaimer:
Please note that while Mucomix Injection is formulated from N-Acetylcysteine (400 mg/2 ml), a clinically established mucolytic and hepatoprotective agent, and is appropriate for use in companion animals including dogs and cats under veterinary supervision on an extra-label basis, it is a prescription-only injectable pharmaceutical and must not be purchased, possessed, or administered without a valid prescription from a licensed veterinarian. This product is not a substitute for a comprehensive veterinary diagnosis, and its use in a toxicity emergency requires immediate professional assessment do not attempt to treat a suspected paracetamol overdose at home. For pets with pre-existing respiratory conditions, asthma, bronchospasm, known hypersensitivity to acetylcysteine, or concurrent medications, consult your veterinarian before administration. Animeal supports your pet's health and happiness journey but does not replace the advice of a qualified veterinary professional.
